C

CymaBay Therapeutics

71 employees

CymaBay Therapeutics is focused on the development and commercialization of proprietary new medicines for critical human diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
Biopharma

Date founded

1991

Funding rounds raised

Total raised

$100M

from 14 investors over 14 rounds

C

CymaBay Therapeutics raised $100M on August 2, 2021

Investors: Abingworth

C

CymaBay Therapeutics raised $5M on December 11, 2013

Investors: Oxford Finance LLC

C

CymaBay Therapeutics raised $8.6M on November 5, 2009

Investors: Charter Life Sciences, Birchmere Ventures, Versant Ventures, Venrock, VantagePoint Venture Partners, Pictet Asset Management and Next Chapter Holdings

C

CymaBay Therapeutics raised $32M on April 19, 2007

Investors: Venrock, Versant Ventures, T. Rowe Price, Pictet Asset Management and VantagePoint Venture Partners

FAQ